|
1
|
Styblo M, Del Razo LM, Vega L, Germolec
DR, LeCluyse EL, Hamilton GA, Reed W, Wang C, Cullen WR and Thomas
DJ: Comparative toxicity of trivalent and pentavalent inorganic and
methylated arsenicals in rat and human cells. Arch Toxicol.
74:289–299. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rosen BP: Biochemistry of arsenic
detoxification. FEBS Lett. 529:86–92. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen GQ, Shi XG, Tang W, Xiong SM, Zhu J,
Cai X, Han ZG, Ni JH, Shi GY, Jia PM, et al: Use of arsenic
trioxide (As2O3) in the treatment of acute
promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual
effects on APL cells. Blood. 89:3345–3353. 1997.PubMed/NCBI
|
|
4
|
Singh ZN, Duong VH, Koka R, Zou Y, Sawhney
S, Tang L, Baer MR, Ambulos N, El Chaer F and Emadi A: High-risk
acute promyelocytic leukemia with unusual T/Myeloid immunophenotype
successfully treated with ATRA and arsenic trioxide-based regimen.
J Hematop. 11:67–74. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Uslu R, Sanli UA, Sezgin C, Karabulut B,
Terzioglu E, Omay SB and Goker E: Arsenic trioxide-mediated
cytotoxicity and apoptosis in prostate and ovarian carcinoma cell
lines. Clin Cancer Res. 6:4957–4964. 2000.PubMed/NCBI
|
|
6
|
Kim YJ, Chung JY, Lee SG, Kim JY, Park JE,
Kim WR, Joo BS, Han SH, Yoo KS, Yoo YH and Kim JM: Arsenic
trioxide-induced apoptosis in TM4 Sertoli cells: The potential
involvement of p21 expression and p53 phosphorylation. Toxicology.
285:142–151. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang H, Jin Y, Jin S, Tan Z, Peng Z and
Kuang Y: Arsenite inhibits the function of CD133+ CD13+ liver
cancer stem cells by reducing PML and Oct4 protein expression.
Tumour Biol. 37:14103–14115. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dilda PJ and Hogg PJ: Arsenical-based
cancer drugs. Cancer Treat Rev. 33:542–564. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Don AS, Kisker O, Dilda P, Donoghue N,
Zhao X, Decollogne S, Creighton B, Flynn E, Folkman J and Hogg PJ:
A peptide trivalent arsenical inhibits tumor angiogenesis by
perturbing mitochondrial function in angiogenic endothelial cells.
Cancer Cell. 3:497–509. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Duzkale H, Jilani I, Orsolic N, Zingaro
RA, Golemovic M, Giles FJ, Kantarjian H, Albitar M, Freireich EJ
and Verstovsek S: In vitro activity of dimethylarsinic acid against
human leukemia and multiple myeloma cell lines. Cancer Chemother
Pharmacol. 51:427–432. 2003.PubMed/NCBI
|
|
11
|
Velloso FJ, Bianco AF, Farias JO, Torres
NE, Ferruzo PY, Anschau V, Jesus-Ferreira HC, Chang TH, Sogayar MC,
Zerbini LF and Correa RG: The crossroads of breast cancer
progression: Insights into the modulation of major signaling
pathways. Onco Targets Ther. 10:5491–5524. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Derakhshan A, Chen Z and Van Waes C:
Therapeutic small molecules target inhibitor of apoptosis proteins
in cancers with deregulation of extrinsic and intrinsic cell death
pathways. Clin Cancer Res. 23:1379–1387. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lam M, Lawrence DA, Ashkenazi A and Walter
P: Confirming a critical role for death receptor 5 and caspase-8 in
apoptosis induction by endoplasmic reticulum stress. Cell Death
Differ. 25:1530–1531. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zimmermann KC, Bonzon C and Green DR: The
machinery of programmed cell death. Pharmacol Ther. 92:57–70. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Taylor RC, Cullen SP and Martin SJ:
Apoptosis: Controlled demolition at the cellular level. Nat Rev.
9:231–241. 2008. View
Article : Google Scholar
|
|
16
|
Cory S and Adams JM: The Bcl2 family:
Regulators of the cellular life-or-death switch. Nat Rev Cancer.
2:647–656. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Antonsson B, Montessuit S, Sanchez B and
Martinou JC: Bax is present as a high molecular weight
oligomer/complex in the mitochondrial membrane of apoptotic cells.
J Biol Chem. 276:11615–11623. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang DC and Strasser A: BH3-Only
proteins-essential initiators of apoptotic cell death. Cell.
103:839–842. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Andreu-Fernández V, García-Murria MJ,
Bañó-Polo M, Martin J, Monticelli L, Orzáez M and Mingarro I: The
C-terminal domains of apoptotic BH3-only proteins mediate their
insertion into distinct biological membranes. J Biol Chem.
291:25207–25216. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Morales AA, Gutman D, Lee KP and Boise LH:
BH3-only proteins Noxa, Bmf, and Bim are necessary for arsenic
trioxide-induced cell death in myeloma. Blood. 111:5152–5262. 2009.
View Article : Google Scholar
|
|
21
|
Liao WT, Chang KL, Yu CL, Chen GS, Chang
LW and Yu HS: Arsenic induces human keratinocyte apoptosis by the
FAS/FAS ligand pathway, which correlates with alterations in
NF-kappaB and AP-1 activity. J Invest Dermatol. 122:125–129. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huyghe E, Matsuda T and Thonneau P:
Increasing incidence of testicular cancer worldwide: A review. J
Urol. 170:5–11. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bertram KA, Bratloff B, Hodges GF and
Davidson H: Treatment of malignant Leydig cell tumor. Cancer.
68:2324–2329. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chang MM, Lai MS, Hong SY, Pan BS, Huang
H, Yang SH, Wu CC, Sun HS, Chuang JI, Wang CY and Huang BM:
FGF9/FGFR2 increase cell proliferation by activating ERK1/2,
Rb/E2F1, and cell cycle pathways in mouse Leydig tumor cells.
Cancer Sci. 109:3503–3518. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Segaloff DL, Ascoli M and Puett D:
Characterization of the desensitized state of Leydig tumor cells.
Biochim Biophys Acta. 675:351–358. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu WC, Hsiao JR, Lian YY, Lin CY and Huang
BM: The apoptotic effect of cordycepin on human OEC-M1 oral cancer
cell line. Cancer Chemother Pharmacol. 60:103–111. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Green LM, Reade JL and Ware CF: Rapid
colorimetric assay for cell viability: Application to the
quantitation of cytotoxic and growth inhibitory lymphokines. J
Immunol Methods. 70:257–268. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Riccardi C and Nicoletti I: Analysis of
apoptosis by propidium iodide staining and flow cytometry. Nat
Protoc. 1:1458–1461. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kang FC, Wang SC, Chang MM, Pan BS, Wong
KL, Cheng KS, So EC and Huang BM: Midazolam activates caspase,
MAPKs and ER stress pathways, and inhibits cell cycle and Akt
pathway, to induce apoptosis in TM3 mouse Leydig progenitor cells.
Onco Targets Ther. 11:1475–1490. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
So EC, Chen YC, Wang SC, Wu CC, Huang MC,
Lai MS, Pan BS, Kang FC and Huang BM: Midazolam regulated caspase
pathway, endoplasmic reticulum stress, autophagy, and cell cycle to
induce apoptosis in MA-10 mouse Leydig tumor cells. Onco Targets
Ther. 9:2519–2533. 2016.PubMed/NCBI
|
|
31
|
Lowry OH, Rosebrough NJ, Farr AL and
Randall RJ: Protein measurement with the Folin phenol reagent. J
Biol Chem. 193:265–275. 1951.PubMed/NCBI
|
|
32
|
Chen YH, Leu SF, Jen CY and Huang BM:
Effects of sesamol on apoptosis and steroidogenesis in MA-10 mouse
Leydig tumor cells. J Agric Food Chem. 59:9885–9891. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pao HY, Pan BS, Leu SF and Huang BM:
Cordycepin stimulated steroidogenesis in MA-10 mouse Leydig tumor
cells through the protein kinase C Pathway. J Agric Food Chem.
60:4905–4913. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen YC, Chen YH, Pan BS, Chang MM and
Huang BM: Functional study of Cordyceps sinensis and cordycepin in
male reproduction: A review. J Food Drug Anal. 25:197–205. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mullen P: PARP cleavage as a means of
assessing apoptosis. Methods Mol Med. 88:171–181. 2004.PubMed/NCBI
|
|
36
|
Hassani S, Khaleghian A, Ahmadian S,
Alizadeh S, Alimoghaddam K, Ghavamzadeh A and Ghaffari SH:
Redistribution of cell cycle by arsenic trioxide is associated with
demethylation and expression changes of cell cycle related genes in
acute promyelocytic leukemia cell line (NB4). Ann Hematol.
97:83–93. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Snow ET: Metal carcinogenesis: Mechanistic
implications. Pharmacol Ther. 53:31–65. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Styblo M, Del Razo LM, LeCluyse EL,
Hamilton GA, Wang C, Cullen WR and Thomas DJ: Metabolism of arsenic
in primary cultures of human and rat hepatocytes. Chem Res Toxicol.
12:560–565. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hong SK, Wu PK and Park JI: A cellular
threshold for active ERK1/2 levels determines Raf/MEK/ERK-mediated
growth arrest versus death responses. Cell Signal. 42:11–20. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Diepart C, Karroum O, Magat J, Feron O,
Verrax J, Calderon PB, Gregoire V, Leveque P, Stockis J, Dauguet N,
et al: Arsenic trioxide treatment decreases the oxygen consumption
rate of tumor cells and radiosensitizes solid tumors. Cancer Res.
72:482–490. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
McCabe MJ, Singh KP, Reddy SA, Chelladurai
B, Pounds JG, Reiners JJ and States JC: Sensitivity of
myelomonocytic leukemia cells to arsenite-induced cell cycle
disruption, apoptosis, and enhanced differentiation is dependent on
the inter-relationship between arsenic concentration, duration of
treatment, and cell cycle phase. J Pharmacol Exp Ther. 295:724–733.
2000.PubMed/NCBI
|
|
42
|
Hayashi T, Hideshima T, Akiyama M,
Richardson P, Schlossman RL, Chauhan D, Munshi NC, Waxman S and
Anderson KC: Arsenic trioxide inhibits growth of human multiple
myeloma cells in the bone marrow microenvironment. Mol Cancer Ther.
1:851–860. 2002.PubMed/NCBI
|
|
43
|
Yuan Z, Wang F, Zhao Z, Zhao X, Qiu J, Nie
C and Wei Y: BIM-mediated AKT phosphorylation is a key modulator of
arsenic trioxide-induced apoptosis in cisplatin-sensitive and
-resistant ovarian cancer cells. PLoS One. 6:e205862011. View Article : Google Scholar : PubMed/NCBI
|
